Rare Disease Trial, Not Yet Recruiting NCT07674550 Sponsor: University Hospital, Toulouse Condition: Rare Disease
Back to Rare Disease

Rare Disease Trial, Not Yet Recruiting

NCT07674550
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Adults aged 18 years or older.
  • People who have been exposed to an infectious disease that is considered emerging or potentially emerging, are at risk of such exposure, are at risk of complications if exposed, or are suspected of having or have been diagnosed with such a disease.
  • People who are receiving, or are expected to receive, newer or experimental treatments for an infectious disease, such as new medicines, checkpoint inhibitors, or cell-based therapies.
  • People who are receiving, or are expected to receive, vaccines or other preventive treatments related to an infectious disease.
  • Women who are pregnant or breastfeeding may be included.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are under a legal guardianship arrangement, such as being under guardianship, curatorship, or a court-ordered guardianship.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 17 August 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Guillaume MARTIN-BLONDEL, MD, PhD, University Hospital, Toulouse

Phone: +33561779699

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 June 2026
Est. completion
14 June 2036

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Collection of biological samples and associated data from patients at risk of acquiring, or affected by, emerging or potentially emerging infectious diseases, including those receiving preventive or curative treatment for such infections

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 17 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov